IRIS
DE VITO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.720
AS - Asia 3.278
SA - Sud America 1.863
EU - Europa 1.452
AF - Africa 137
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
AN - Antartide 1
Totale 17.465
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.528
BR - Brasile 1.661
SG - Singapore 1.456
CN - Cina 539
IT - Italia 436
HK - Hong Kong 423
VN - Vietnam 344
DE - Germania 271
FR - Francia 147
FI - Finlandia 140
GB - Regno Unito 105
CA - Canada 86
AR - Argentina 78
IN - India 72
BD - Bangladesh 64
MX - Messico 61
TR - Turchia 52
UA - Ucraina 50
RU - Federazione Russa 48
NL - Olanda 39
IQ - Iraq 37
ZA - Sudafrica 36
EC - Ecuador 35
PK - Pakistan 34
ES - Italia 29
JP - Giappone 29
VE - Venezuela 28
PL - Polonia 26
ID - Indonesia 25
CZ - Repubblica Ceca 24
MA - Marocco 24
CO - Colombia 23
UZ - Uzbekistan 23
SE - Svezia 22
AT - Austria 19
KR - Corea 19
AE - Emirati Arabi Uniti 18
LT - Lituania 15
IL - Israele 14
NP - Nepal 14
BE - Belgio 13
JM - Giamaica 13
KE - Kenya 12
TN - Tunisia 12
AZ - Azerbaigian 11
KG - Kirghizistan 11
PS - Palestinian Territory 11
UY - Uruguay 11
JO - Giordania 10
MY - Malesia 10
SA - Arabia Saudita 10
DO - Repubblica Dominicana 9
RO - Romania 9
RS - Serbia 9
UG - Uganda 9
CL - Cile 8
IE - Irlanda 8
LB - Libano 8
PE - Perù 8
PH - Filippine 8
PY - Paraguay 7
SN - Senegal 7
AU - Australia 6
BG - Bulgaria 6
DZ - Algeria 6
EG - Egitto 6
AL - Albania 5
GE - Georgia 5
HU - Ungheria 5
KZ - Kazakistan 5
OM - Oman 5
TH - Thailandia 5
AM - Armenia 4
CI - Costa d'Avorio 4
HN - Honduras 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BN - Brunei Darussalam 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
GR - Grecia 3
MK - Macedonia 3
NI - Nicaragua 3
XK - ???statistics.table.value.countryCode.XK??? 3
BW - Botswana 2
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
MT - Malta 2
MZ - Mozambico 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
Totale 17.434
Salva come PNG Salva come JPEG
Città #
Dallas 7.703
Singapore 770
San Jose 528
Hong Kong 420
Chandler 345
Ashburn 325
New York 231
Beijing 202
Munich 165
São Paulo 129
Los Angeles 112
Lauterbourg 110
Ho Chi Minh City 104
Helsinki 101
Hanoi 79
Princeton 68
Sassari 63
Rio de Janeiro 60
Santa Clara 57
Shanghai 55
Belo Horizonte 51
Brasília 37
Rome 37
Orem 35
Cagliari 33
Montreal 33
Columbus 32
Boardman 31
Curitiba 30
Denver 30
Council Bluffs 29
Frankfurt am Main 27
Tokyo 27
Atlanta 24
Brno 24
London 24
Warsaw 24
Chicago 23
Amsterdam 22
Chennai 22
San Francisco 22
Brooklyn 21
Campinas 21
Buffalo 20
Johannesburg 20
The Dalles 20
Toronto 20
Fortaleza 19
Salvador 19
Nuremberg 18
Phoenix 18
Tashkent 18
Haiphong 17
Palermo 17
Poplar 17
Seoul 17
Turku 17
Boston 16
Dhaka 16
Guarulhos 16
Guayaquil 16
Porto Alegre 16
Recife 16
Wilmington 16
Lappeenranta 15
Mexico City 15
Sorocaba 15
Stockholm 15
Ankara 14
Da Nang 14
Falkenstein 14
Baghdad 13
Goiânia 13
Houston 13
Lahore 13
Mumbai 13
Ribeirão Preto 13
Düsseldorf 12
São José dos Campos 12
Bishkek 11
Brussels 11
Contagem 11
Florianópolis 11
Istanbul 11
Manchester 11
Nairobi 11
Santo André 11
Xi'an 11
Alghero 10
Amman 10
Baku 10
Jacksonville 10
Ottawa 10
Romola 10
Buenos Aires 9
Kampala 9
Milan 9
Nova Iguaçu 9
Osasco 9
Querétaro 9
Totale 13.072
Salva come PNG Salva come JPEG
Nome #
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 838
Chain of thought reasoning in enhancing infectious disease diagnosis and microbiological analysis 732
Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives 652
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort 646
Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country 571
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 535
Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections– results from a retrospective multicentre study 529
Diagnostic Performance of ChatGPT-4o in Analyzing Oral Mucosal Lesions: A Comparative Study with Experts 516
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 328
Assessing the Accuracy, Completeness and Safety of ChatGPT-4o Responses on Pressure Injuries in Infants: Clinical Applications and Future Implications 280
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 276
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 263
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort 260
Efficacy and safety of B/F/TAF in naïve people with HIV: real life data from the SHiNeSHiC research group 254
Rare or Unusual Non-Fermenting Gram-Negative Bacteria: Therapeutic Approach and Antibiotic Treatment Options 250
Fluoroquinolones and Biofilm: A Narrative Review 238
A case of vasculitis-like skin eruption associated with COVID-19 206
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 182
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 174
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 166
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 166
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 166
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 160
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 155
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 153
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 152
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 144
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 143
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 142
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 140
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 138
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 137
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 134
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 130
Exploring the Impact of Cabotegravir-Rilpivirine Long-Acting on Weight Gain, Body Composition, and Quality of Life in Adults Living with HIV 129
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 129
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 129
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 128
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 127
Coronavirus disease 2019 (COVID-19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus-2 (SARS-CoV-2) Omicron variant 127
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 125
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 125
Bone safety of dolutegravir-containing regimens in people living with HIV: Results from a real-world cohort 124
Infectious diseases screening approach among refugees: Results from a single-center study 124
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 123
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 122
Early combination treatment with existing HIV antivirals: An effective treatment for COVID-19? 122
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 122
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 117
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 116
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 115
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 115
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 115
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes 113
HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects 111
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study 110
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 107
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 107
Human urogenital schistosomiasis in West and Sub-Saharan Africa migrants in Sardinia, Italy: A retrospective monocentric study 106
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study 105
What do We Know about Cryptic Aspergillosis? 105
Living with HIV and Getting Vaccinated: A Narrative Review 105
Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort 103
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter? 103
HBV in Italian Women’s Jail: An Underestimated Problem? 101
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 100
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) 99
The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients 99
The current and future off-label uses of dalbavancin: a narrative review 98
Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in Italy 97
Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel 96
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 96
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up 96
Women Living with HIV in Italian Prison Settings: Results from the Gender-Specific ROSE Network 94
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study 93
Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges 91
Is oral antibiotic therapy as effective as intravenous treatment in bacterial osteomyelitis? A real-life experience 90
Severity of lung involvement on chest x-rays in sars-coronavirus-2 infected patients as a possible tool to predict clinical progression: An observational retrospective analysis of the relationship between radiological, clinical, and laboratory data 90
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 89
New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS) 88
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 88
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 88
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 87
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience 86
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments 85
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 84
Knowledge, Attitudes, and Practices toward Antimicrobial Resistance among Young Italian Nurses and Students: A Multicenter, Cross-Sectional Study 84
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding 83
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 82
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 78
Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort 78
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 78
In Response to Smell and Taste Loss in COVID-19 After Complete Vaccination: Correspondence 78
Perspectives on climate action and the changing burden of infectious diseases among young Italian doctors and students: a national survey 77
Editorial - HIV and cancer during COVID-19 pandemic: Sailing through the perfect storm 77
Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era 76
New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature 75
Enhancing AI Chatbot Responses in Health Care: The SMART Prompt Structure in Head and Neck Surgery 71
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen 69
Reply letter - “Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: A nationwide comparative analysis” 69
Totale 16.575
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022177 4 4 5 1 1 4 1 5 8 18 41 85
2022/2023646 44 74 20 96 47 97 25 80 97 15 39 12
2023/2024535 38 28 20 27 194 92 4 7 2 5 34 84
2024/20253.718 50 36 183 136 159 151 387 643 1.139 540 185 109
2025/202612.427 322 1.344 6.909 955 757 331 853 182 276 346 115 37
Totale 17.650